These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 14562565)

  • 1. Clinical potential of blood substitutes or oxygen therapeutics during cardiac surgery.
    Wahr JA
    Anesthesiol Clin North Am; 2003 Sep; 21(3):553-68. PubMed ID: 14562565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haemoglobin-based erythrocyte transfusion substitutes.
    Standl T
    Expert Opin Biol Ther; 2001 Sep; 1(5):831-43. PubMed ID: 11728218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of haemoglobin glutamer-250 (HBOC-201) as an oxygen bridge in patients with acute anaemia associated with surgical blood loss.
    Levy JH
    Expert Opin Biol Ther; 2003 Jun; 3(3):509-17. PubMed ID: 12783619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Autologous transfusion - from euphoria to reason: clinical practice based on scientific knowledge. (Part IV). Artificial oxygen carriers: cell-free hemoglobin solutions -- current status 2004].
    Standl T
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2005 Jan; 40(1):38-45. PubMed ID: 15645386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemoglobin-based oxygen carrier HBOC-201 provides higher and faster increase in oxygen tension in skeletal muscle of anemic dogs than do stored red blood cells.
    Standl T; Freitag M; Burmeister MA; Horn EP; Wilhelm S; Am Esch JS
    J Vasc Surg; 2003 Apr; 37(4):859-65. PubMed ID: 12663989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymerized bovine hemoglobin solution as a replacement for allogeneic red blood cell transfusion after cardiac surgery: results of a randomized, double-blind trial.
    Levy JH; Goodnough LT; Greilich PE; Parr GV; Stewart RW; Gratz I; Wahr J; Williams J; Comunale ME; Doblar D; Silvay G; Cohen M; Jahr JS; Vlahakes GJ
    J Thorac Cardiovasc Surg; 2002 Jul; 124(1):35-42. PubMed ID: 12091806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential clinical applications for blood substitutes.
    Winslow RM
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):205-17. PubMed ID: 1391435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical potential of nonhemoglobin oxygen therapeutics in cardiac and general surgery.
    Wahr JA
    Am J Cardiovasc Drugs; 2002; 2(2):69-75. PubMed ID: 14727983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood substitutes.
    Winslow RM
    Adv Drug Deliv Rev; 2000 Feb; 40(3):131-42. PubMed ID: 10837785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Artificial oxygen carriers as an alternative to red blood cell transfusion].
    Habler O; Pape A; Meier J; Zwissler B
    Anaesthesist; 2005 Aug; 54(8):741-54. PubMed ID: 16021390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood substitutes.
    Winslow RM
    Curr Opin Hematol; 2002 Mar; 9(2):146-51. PubMed ID: 11844999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemoglobin-based oxygen carrier preserves submaximal exercise capacity in humans.
    Hughes GS; Yancey EP; Albrecht R; Locker PK; Francom SF; Orringer EP; Antal EJ; Jacobs EE
    Clin Pharmacol Ther; 1995 Oct; 58(4):434-43. PubMed ID: 7586936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Doping with artificial oxygen carriers: an update.
    Schumacher YO; Ashenden M
    Sports Med; 2004; 34(3):141-50. PubMed ID: 14987124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review of hemoglobin-vesicles as artificial oxygen carriers.
    Sakai H; Sou K; Horinouchi H; Kobayashi K; Tsuchida E
    Artif Organs; 2009 Feb; 33(2):139-45. PubMed ID: 19178458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of a hemoglobin-based oxygen carrier (HBOC-201) on hemodynamics and oxygen transport in patients undergoing preoperative hemodilution for elective abdominal aortic surgery.
    Kasper SM; Walter M; Grüne F; Bischoff A; Erasmi H; Buzello W
    Anesth Analg; 1996 Nov; 83(5):921-7. PubMed ID: 8895264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current aspects in pharmacology of modified hemoglobins.
    Palaparthy R; Wang H; Gulati A
    Adv Drug Deliv Rev; 2000 Feb; 40(3):185-98. PubMed ID: 10837789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional blood flow after serial normovolemic exchange transfusion with HBOC-201 (Hemopure) in anesthetized swine.
    Mongan PD; Moon-Massat PF; Rentko V; Mihok S; Dragovich A; Sharma P
    J Trauma; 2009 Jul; 67(1):51-60. PubMed ID: 19590308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perfluorocarbons in the twenty-first century: clinical applications as transfusion alternatives.
    Spence RK
    Artif Cells Blood Substit Immobil Biotechnol; 1995; 23(3):367-80. PubMed ID: 7493058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New transfusion strategies: red cell substitutes.
    Winslow RM
    Annu Rev Med; 1999; 50():337-53. PubMed ID: 10073282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HBOC-201 vasoactivity in a phase III clinical trial in orthopedic surgery subjects--extrapolation of potential risk for acute trauma trials.
    Freilich D; Pearce LB; Pitman A; Greenburg G; Berzins M; Bebris L; Ahlers S; McCarron R
    J Trauma; 2009 Feb; 66(2):365-76. PubMed ID: 19204509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.